T umours abundantly release cancer cells into the circulation, but only a small proportion of these cells succeed at seeding in distant organs. Following a latency period that can last from months to years, disseminated cancer cells (DCCs) may grow and form clinically overt metastatic lesions [1] [2] [3] . Once metastasis is manifest, current treatments often fail. Metastatic colonization involves in part a varied set of organ-specific interactions between the DCCs and their surrounding stroma 4 , and the diversity of these interactions, together with the intrinsic heterogeneity of tumours, pose serious challenges to the development of treatments against disseminated cancer. Identification of common mediators of metastatic colonization that may function in multiple organs is therefore critically important.
T umours abundantly release cancer cells into the circulation, but only a small proportion of these cells succeed at seeding in distant organs. Following a latency period that can last from months to years, disseminated cancer cells (DCCs) may grow and form clinically overt metastatic lesions [1] [2] [3] . Once metastasis is manifest, current treatments often fail. Metastatic colonization involves in part a varied set of organ-specific interactions between the DCCs and their surrounding stroma 4 , and the diversity of these interactions, together with the intrinsic heterogeneity of tumours, pose serious challenges to the development of treatments against disseminated cancer. Identification of common mediators of metastatic colonization that may function in multiple organs is therefore critically important.
A common characteristic of DCCs, visualized by intravital imaging, is their persistence at the perivascular niche during metastatic colonization of secondary organs such as the brain, lungs and liver [5] [6] [7] . Perivascular localization provides DCCs with ready access to oxygen, nutrients and endothelium-derived paracrine factors that enhance self-renewal, proliferation and survival 8, 9 , influencing metastatic latency and eventual outbreaks 10, 11 . Metastatic growth within the perivascular niche, a process known as vascular cooption, precedes macro-metastatic outgrowth 5, 12 . We recently showed that, despite capillaries supplying plenty of oxygen and nutrients, perivascular localization of breast and lung cancer cells is not sufficient for their outgrowth in the brain 13 . DCCs additionally need to spread over the abluminal surface of blood vessels, which is encapsulated by a collagen-and laminin-rich basal lamina. This spreading requires the cell adhesion molecule L1CAM 13 , a molecule that is normally restricted to developing neurons and certain haematological and endothelial cells, but whose expression in many tumour types is associated with an unfavourable clinical outcome [14] [15] [16] . The precise role of L1CAM in cancer metastasis has remained unclear. L1CAM has been implicated in cancer cell migration in vitro 17 . However, in vivo, L1CAM-deficient metastatic cells can reach the circulation and extravasate through brain capillaries, suggesting that L1CAM is not rate limiting for the early migratory steps of the metastatic cascade 13 . After extravasating in the brain parenchyma, L1CAM-deficient cells can still occupy the perivascular niche, but they fail to spread on the basal lamina and to grow 13 . Here, we have determined the mechanism and significance of L1CAM-mediated metastatic outgrowth. DCC spreading via L1CAM activates the mechanotransduction effectors YAP and MRTF, which are necessary for DCC growth in multiple organs. At the molecular level, metastatic cells mimic a previously unknown role of L1CAM in pericytes, the perivascular mesenchymal cells that regulate blood vessel haemostasis 18 . We identify ILK, a core component of pericyte spreading machinery, as a downstream mediator of L1CAM-dependent YAP activation. These findings suggest a basis for L1CAM-dependent initiation of metastatic colonization in various organ sites by different tumour types, both by aggressive cancer cells and by latent metastatic cells.
. The position and morphology of these cells were reminiscent of pericytes, which express chondroitin sulfate proteoglycan 4 (Cspg4, also known as neural/glial antigen 2, NG2) (Fig. 1a) . Pericytes and H2030-BrM cells also spread similarly along endothelial cell tubules on matrigel, whereas non-tumourigenic cells did not ( Supplementary Fig. 1a ). Imaging of pericytes in the context of metastatic lesions in mice revealed that haematogenously disseminated H2030-BrM cells spreading on brain capillaries wedged between pericytes and capillary surfaces (Fig. 1b) . To better understand this process, we tracked cancer cells in 250-μ m-thick coronal mouse brain slice culture (BSC) model for two days. Metastatic cells placed on top of live brain sections infiltrate the tissue, migrate towards capillaries, and then use L1CAM to spread and proliferate on capillary surfaces, providing a model for studying perivascular events of metastasis seeding 13 . Despite approaching the endothelial cells and the resident pericytes from the abluminal side of the blood vessels, metastatic cells wedged between pericytes and endothelial cells in addition to localizing on top of pericytes or across from them on the same capillary ( Supplementary Fig. 1b ). Cspg4-expressing stromal cells closely interacting with cancer cells were positive for platelet-derived growth factor receptor β (PDGFRβ ), but not for the oligodendrocyte progenitor marker O4, confirming these cells as pericytes ( Supplementary Fig. 1d-e) .
Next, we used genetically engineered mice expressing Discosoma sp. red (DsRed) fluorescence protein under the control of the Cspg4 promoter to track pericytes during time-lapse confocal imaging of organotypic BSCs. Time-lapse imaging showed that H2030-BrM cells migrated along the vessels and transiently dislodged pericytes (Fig. 1c, Supplementary Fig. 1f and Supplementary Videos 1 and 2). Following transit of metastatic cells, pericytes reattached to the capillaries, suggesting that pericyte-cancer cell competition for the perivascular niche is more frequent than can be observed in still images. In contrast, when L1CAM-knockdown cancer cells encountered pericytes, they stalled or changed the direction of their migration on the capillary surfaces, and eventually adopted a round morphology (Fig. 1c, Supplementary Fig. 1f and Supplementary Videos 3 and 4). L1CAM-knockdown cells did not detach from the capillaries, suggesting that L1CAM was rate limiting specifically for cancer cell spreading on capillaries but not for cell adhesion or migration. Metastatic cell colonization along mouse brain capillaries in vivo also correlated with a reduction in pericyte coverage compared to adjacent vasculature devoid of cancer cells ( Fig. 1d and Supplementary Fig. 1g ).
To capture pericyte-DTC interactions during metastasis initiation in human cancer, we turned to clinical tissues. Because these interactions represent early metastatic events and can be influenced by therapeutic drugs, we sought tissue from patients with clinically silent, untreated micrometastatic disease. Using these stringent criteria, we focused on brain tissue obtained at autopsy of one treatment-naive ER + breast cancer patient with occult brain metastases as small as 50 μ m in diameter. Immunostaining of pericytes and vascular mural cells with smooth muscle α -actin (α SMA), endothelial cells (CD31) and cancer cells (panKeratin) showed close interactions between cancer cells, endothelial cells and mesenchymal pericytes ( Supplementary Fig. 1h,i) . Despite the rarity of this treatment-naive patient tissue sample, the data add to our evidence that L1CAM
+ metastatic cancer cells access the perivascular niche and can displace pericytes at the initiation of metastatic colonization.
L1CAM is necessary for metastatic colonization in multiple organs. Pericytes cover capillaries in many tissues, and L1CAM expression in primary tumours is associated with metastatic relapse in multiple organs 14 . Therefore, we determined whether L1CAM was necessary for metastasis to multiple organs. Although MDA231-BrM cells were elongated over the web-like cerebral capillaries for pericyte-like spreading, the lung metastatic MDA231-LM cells 21 presented with multiple protrusions after infiltrating the pulmonary parenchyma ( Fig. 2a and Supplementary Fig. 2a,b) . These protrusions extended over the adjacent multi-branched capillary network of pulmonary alveoli, and were reduced by L1CAM knockdown (Fig. 2a) . Conversely, L1CAM over-expression in MDA-MB-468 breast cancer cells, which have lower L1CAM levels, increased the spreading of these cells on brain capillaries ( Supplementary Fig.  2c-e) . In lungs, metastatic cell protrusions resembled filopodia-like structures previously described in lung metastasis 22, 23 and lung pericytes 24 , suggesting that the pericyte-like spreading morphology varied depending on capillary network architecture in the host organ.
The involvement of L1CAM in lung colonization by MDA231-LM cells was also observed in metastasis from orthotopic tumours. L1CAM knockdown in MDA231-LM cells reduced their tumourigenic growth in mouse mammary fat pads (Fig. 2b) , and also decreased spontaneous lung metastasis burden normalized to implanted tumour size in these mice (Fig. 2c,d ). L1CAM knockdown also inhibited vascular spreading of the disseminated cancer cells in the liver and lungs (Fig. 2e,f) . To determine the effect of L1CAM knockdown in metastatic colonization in secondary organs without its confounding effect on a source orthotopic tumour, we injected cancer cells directly into the circulation. L1CAM knockdown strongly inhibited lung and bone colonization by MDA231-LM and MDA231-BoM cells, respectively (Fig. 2g,h and Supplementary Fig. 2f ). L1CAM knockdown also inhibited brain metastasis of Kras
G12D
;p53 −/− mouse lung adenocarcinoma 393N1 cell line 25 , which metastasizes to brain 13 and coopts brain capillaries ( Supplementary Fig. 2g ), when these cells were injected into the intracardiac circulation of immunocompetent mice (Fig. 2i) . Additionally, L1CAM knockdown significantly inhibited multiorgan colonization by 786-M1A renal cancer cells and liver colonization by HCT116 colon cancer cells (Figs. 2j-l) . L1CAM depletion did not affect cancer cell growth in monolayer culture or viability in suspension culture, suggesting that the previously described role of L1CAM in cancer cell proliferation and survival in vitro 17 is not sufficient to explain its function in metastatic colonization ( Supplementary Fig. 2h-j) .
To determine whether L1CAM played a role in the metastatic cascade following extravasation and initial positioning on capillaries in secondary organs, we used a doxycycline-inducible L1CAM shRNA vector ( Supplementary Fig. 3a-d ). In the MDA231-LM, MDA231-BoM and H2030-BrM models, extravasation in target organs is complete in 2 days in lung and 7 days in brain after cell inoculation into the circulation 5, 6, 13 . Doxycycline treatment 9 days after cell injections in mice inhibited the subsequent metastatic outgrowths in lungs, bones and brain ( Fig. 3a-d) , demonstrating a post-extravasation role of L1CAM in all these sites.
Role of L1CAM during emergence from metastatic latency. The emergence of clinically manifest metastases is often preceded by a latency period [1] [2] [3] . During latency, metastasis-initiating cells exist in a dynamic equilibrium, in which intrinsic and extrinsic factors regulate cell entry into an immune-evasive, slow-cycling state 10 . To probe the role of L1CAM in this important stage of metastasis, we used HCC1954-LCC1 cells, a latency competent cancer cell model isolated from an early-stage HER2 + breast tumour 10 . After extravasating in the brain of athymic mice, HCC1954-LCC1 cells initially spread on brain capillaries 10 , but within 14 days most of the disseminated cells cease to spread, and they become round and enter a slow Articles NATuRe CeLL BIOLOgY proliferative state to remain latent for extended periods 10 . Periodic re-entry of these cells into the proliferative state triggers NKG2D ligand expression for cancer cell recognition and elimination by natural killer (NK) cells. L1CAM knockdown reduced the initial spreading of HCC1954-LCC1 (Supplementary Fig. 4a ).
NK interactions with HCC1954-LCC1 metastatic foci in brains of mice were observable 30 days after intracardiac injections (Fig. 4a) . We induced NK cell depletion by administering antiasialo-GM1 ganglioside (anti-GM1) antibody to mice harbouring latent HCC1954-LCC1 populations, a treatment that allows the 
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NATuRe CeLL BIOLOgY progressive outgrowth of metastatic lesions 10 . Cancer cells that entered the proliferative state under these conditions formed colonies wrapping the vasculature, providing a model in which to test the role of L1CAM in metastatic outgrowth after elimination of innate immune surveillance (Supplementary Fig. 4b ).
We subjected HCC1954-LCC1 cells expressing a doxycyclineinducible shL1CAM vector to this latency outbreak protocol (Fig. 4b) . Doxycycline administration to mice 14 days after cancer cell inoculation did not significantly affect metastatic foci in the presence of NK cells. However, L1CAM knockdown induction two days before + alveolar capillaries (red) after tail vein injection and extravasation into the mouse lungs ('as', alveolar spaces). Scale bars, 10 μ m. The bar graph shows mean vascular coopting protrusions per metastatic foci (n = 36 foci pooled from 2 mice per group). b, Mean mammary tumour volume in mice orthotopically injected with MDA231-LM cells (n = 14 and 12 mammary fat pads injected with control and shL1CAM cells; two mammary fat pads per mice). c, Lung BLI (bioluminescence) of mice in b normalized to total tumour volume for each mouse at euthanasia. Box plots: median, 25th and 75th percentiles. Whiskers: minimum and maximum (n = 7 and 6 mice for control and shL1CAM groups). d, Representative BLI of lungs and livers of mice in b. e,f, Representative images of GFP + MDA231-LM cells (green) disseminated to the livers (e) and lungs (f) of mice in b; CD31 + capillaries, red. Scale bars, 1 μ m (e) and 20 μ m (f). Images in a,e,f are from 80-μ m-thick tissue sections. g-l, BLI in indicated sites in mice injected with the indicated cell lines with representative BLI shown in g,h,j (n = 9 mice per group in g,h; n = 15 mice per group in i; n = 12 and 13 mice control and shL1CAM group in j; n = 9 and 5 mice per control and shL1CAM group in k; n = 5 mice per group in l). Graphs in g,h,j represent mean BLI intensities; **P < 0.01; ***P < 0.001. Error bars in a,b,g,h,j are s.e.m. P values in b,g,h,j are calculated using a two-tailed unpaired t-test not assuming equal standard deviations. 
NATuRe CeLL BIOLOgY initiation of NK cell depletion prevented HCC1954-LCC1 from spreading and proliferating on capillaries to form metastatic colonies, and inhibited DCC exit from metastatic latency (Fig. 4c-e and Supplementary Fig. 4c-e) . In sum, L1CAM was required for the outgrowth of aggressive metastasis-initiating cells immediately after extravasation and of latent metastatic cells after exiting from quiescence (Fig. 4f) .
L1CAM-driven transcriptional programs for metastasis initiation. The perivascular environment is rich in oxygen, nutrients and growth factors 8, 9 , yet metastatic cells that lose L1CAM expression cannot grow in this environment 13 (Figs. 2-4 ). To identify events downstream of L1CAM that license metastasis-initiating cells for growth in this context, we investigated the gene expression patterns of control and L1CAM-knockdown H2030-BrM cells on brain capillaries in BSC. We engineered H2030-BrM cells expressing ribosomal protein L10a fused to enhanced green fluorescence protein (L10a-eGFP), and performed translating ribosome affinity purification and mRNA sequencing (TRAP-seq) 26 ( Fig. 5a ). Gene set enrichment analysis of the L1CAM-mediated gene expression profile in brain slice cultures with classifiers that denote activation of specific pathways revealed a selective, L1CAM-dependent increase in YAP and MRTF-A transcriptional signatures ( Fig. 5b and Supplementary Fig. 5a ). Less pronounced gains occurred in Ras, hedgehog and nuclear factor κ B (NF-κ B) transcriptional signatures ( Supplementary Fig. 5b ). YAP, the closely related TAZ and MRTF-A (encoded by MKL1) are transcriptional co-activators that relay signalling initiated by cell density and contact cues, cytoskeletal dynamics and cellular tension by nuclear translocation and activation of gene expression programs for proliferation, motility and adhesion 27, 28 . YAP and MRTF have been implicated in metastasis 29, 30 . Using quantitative PCR with reverse transcription (qRT-PCR), we confirmed that L1CAM knockdown reduced the expression of YAP and MRTF-A target genes ( Supplementary Fig. 5c,d ).
Next, we engineered a lentiviral YAP promoter reporter construct to assess YAP activity in situ. By fusing a destabilization domain (DD) 31 to the N terminus of red fluorescence protein (RFP) under the control of a YAP-responsive promoter (8xGTIIC) 32 , we measured spatiotemporal YAP activity. In the absence of a stabilizer compound (trimethoprim) or YAP activity, YAP-driven RFP expression is undetectable because RFP is quickly degraded or not transcribed, respectively. Adding the stabilizer to cells leads to RFP accumulation when YAP is active (Fig. 5c ). YAP knockdown and latrunculin A treatment, which prevents actin polymerization and YAP nuclear localization 32 , reduced RFP signal, validating our approach ( Supplementary Fig. 5e ,f). L1CAM knockdown in MDA231-BrM and H2030-BrM cells significantly reduced RFP signal in brain tissue cultures, suggesting that L1CAM regulates YAP activity during pericyte-like spreading in situ (Fig. 5d,e) . However, L1CAM knockdown did not significantly affect phosphorylation of YAP or its upstream Hippo pathway kinases 33 ( Supplementary Fig. 5g ), suggesting that L1CAM regulation of YAP may be parallel to the canonical Hippo pathway and related to YAP regulation by actin cytoskeleton and tension 32, 34, 35 . The potential involvement of YAP and MRTF-A as downstream effectors suggested a link between mechanotransduction signalling and L1CAM-dependent initiation of metastatic growth. Knockdown of YAP or TAZ reduced brain metastasis, both in the H2030-BrM and MDA231-BrM models (Fig. 5f ). Knockdown of MRTF-A/MKL1 inhibited metastasis in H2030-BrM ( Fig. 5g) but not MDA231-BrM cells (data not shown), suggesting cell-type-specific differences in the requirement for MRTF-A in these models. Without substantially affecting the growth of the cells in monolayer culture, YAP knockdown L1CAM regulates YAP nuclear localization during metastatic colonization. Since YAP signalling scored as the most salient mediator of L1CAM-dependent metastasis in these models, we focused on further analysis of this pathway. Using metastasis tissue samples from breast and lung patients with disseminated disease, we focused on cancer cell clusters located on or near CD31-positive blood capillaries. L1CAM immunohistochemical staining was present in the boundaries of cancer cells with the vasculature and with each other (Fig. 6a ). This was similar to the pattern of L1CAM staining in our experimental models (Fig. 6b) . YAP is active when localized to the nucleus. Analyses of adjacent sections from the same tissue block revealed that despite considerable inter-and intra-tumoural heterogeneity, a substantial proportion of L1CAM + metastatic cells Fig. 6a,b) . YAP was predominantly nuclear in H2030-BrM, MDA231-BrM and MDA231-LM cells spreading on brain or lung capillaries, whereas L1CAM knockdown decreased the nuclear localization of YAP (Fig. 6c,d and Supplementary Fig. 6b,c) . Collectively, these results suggest a role for L1CAM upstream of YAP.
To determine whether L1CAM-mediated YAP activation was sufficient to promote metastatic colonization, we performed genetic rescue experiments. Expression of the constitutively nuclear mutant YAP 5SA restored YAP target gene expression ( Supplementary Fig. 5c ) and metastatic activity in L1CAM-depleted cells (Fig. 6e) , whereas YAP S94A , which is deficient in binding the pro-growth TEA domain containing (TEAD) transcription factor 27 , did not. Expression of these YAP mutants did not affect the cell growth in culture (Supplementary Fig. 6c ). Furthermore, YAP 5SA expression did not augment the metastatic activity of H2030-BrM or MDA231-BrM cells, indicating that endogenous YAP is not rate limiting when L1CAM is present (Fig. 6f) . Taken together, these results suggest that L1CAM activates YAP signalling to initiate metastatic colonization.
Role of L1CAM in pericyte spreading. Next, we investigated the mechanistic link between L1CAM, pericyte-like spreading and subsequent YAP activation. Because of extensive pericyte-DCC interactions and similarities in their morphologies and positioning, we postulated that metastatic cells and pericytes share molecular machinery for interaction with endothelial basement membranes. We found that human primary pericytes express L1CAM at the mRNA and protein levels. Moreover, pericytes, like cancer cells, predominantly express the non-neuronal L1CAM isoforms, which lack the two alternatively spliced exons included in the neuronal L1CAM isoform 36 ( Fig. 7a,b) . Because L1cam-null mice do not present vascular defects 16 , we investigated the role of pericyte L1CAM during vascular stress and neoangiogenesis. Lipopolysaccharide (LPS) administration in mice causes systemic inflammation, which results in loosening of the vascular junctions allowing for increased vessel permeability and leakage, coupled with reduced pericyte coverage 37 . Thus, further perturbing pericyte function during LPS treatment augments vascular leakage 38 . To determine if L1CAM has a role in pericyte function, we crossed L1cam fl/fl mice 39 with pericyte-specific tamoxifen-inducible Cre expressing Cspg4-CreERT2 mice 40 . Indeed, pericyte-specific L1cam knockout in Cspg4-CreERT2 L1cam fl/y mice augmented LPS-mediated vascular permeability, as measured by Evans blue dye diffusion from dermal capillaries (Fig. 7c) .
Next, we determined the role of pericyte L1cam during neoangiogenesis in vivo. Sub-cutaneous matrigel implantation in mice leads to endothelial and mural cell invasion and formation of capillary structures that ultimately result in blood flow and erythrocyte accumulation within plugs 41 . In this neo-angiogenesis assay, Table 1 for statistics source data and Supplementary Fig. 8 for unprocessed blots.
NATuRe CeLL BIOLOgY pericyte-specific L1cam knockout reduced erythrocyte accumulation into the plugs, suggesting that maximal neo-angiogenic response required L1CAM (Fig. 7d) . L1CAM knockout in human pericytes inhibited their spreading along endothelial tubules in vitro (Fig. 7e,f) . These results suggest that pericytes use L1CAM for vascular homeostasis under conditions of vascular stress and neoangiogenesis, and metastasis-initiating cells use similar machinery for perivascular spreading and outgrowth. Table 1 for statistics source data and Supplementary Fig. 8 for unprocessed blots.
NATuRe CeLL BIOLOgY L1CAM increases β 1 integrin-ILK signalling for YAP nuclear localization. Because both metastatic cells and pericytes use L1CAM for perivascular spreading, we reasoned that metastatic cells might activate YAP by employing molecular machinery that pericytes use for vessel investment. β 1 integrin and ILK constitute the core machinery that regulates pericyte adhesion to the developing vasculature 42, 43 . Pericyte-specific knockout of Itgb1 or Ilk in mice decreases pericyte association with underlying endothelium and causes embryonic lethality with severe defects in vessel formation 42, 43 . Indeed, ILK knockdown in primary human pericytes inhibited their spreading on endothelial tubules (Fig. 7g) , thus phenocopying the effect of L1CAM knockdown in pericytes in this assay (Fig. 7f) . Moreover, breast cancer metastasis to lungs requires β 1 integrin and ILK 22, 23 , the latter of which has been linked to YAP activity in cancer cell lines 44 . Therefore, we postulated that ILK provides a common link between these various observations.
We first tested the role of ILK in pericytic spreading of DCCs. ILK knockdown suppressed vascular cooption in H2030-BrM cells in BSC (Fig. 7h) and in vivo (Fig. 7i) . ILK knockdown also inhibited the metastatic colonization of brain, lungs and bones by H2030 and MDA231 organotropic derivatives (Fig. 8a-c) . Similar to L1CAM and YAP, inducible ILK knockdown after metastatic seeding inhibited metastatic colonization ( Supplementary Fig. 7a,b) . Together, these results suggested that ILK is necessary for metastatic cell spreading and outgrowth, as is L1CAM. Next, we determined whether L1CAM activates β 1 integrin and ILK. L1CAM and its interacting protein ankyrin-2 are implicated in β 1 integrin activation 45 . To determine whether L1CAM activates β 1 integrin in our model, we plated H2030-BrM cells either on type I collagen or poly-L-lysine to support cell adhesion with or without accompanying robust integrin activation, respectively. Immunolabelling cells with an antibody that specifically recognizes the active conformation of β 1 integrin 46 revealed that L1CAM knockdown reduced β 1 integrin activation in H2030-BrM cells plated on collagen down to the basal level of cells plated on poly-L-lysine ( Fig. 8d and Supplementary  Fig. 7c ). Additionally, ankyrin-2 could be co-immunoprecipitated with L1CAM ( Supplementary Fig. 7d ) and ankyrin-2 knockdown reduced β 1 integrin activation (Supplementary Fig. 7e ).
β 1 integrin signalling through ILK triggers p21-activated phosphorylation of kinase 1 and 2 (PAK1/2), which promotes filamentous actin (F-actin)-rich filopodia-like protrusions. These protrusions precede metastatic colonization of breast cancer cells in the lung 22, 23 . In H2030-BrM cells, L1CAM knockdown inhibited PAK1/2 phosphorylation induced by β 1 integrin engagement on collagen or by β 1 integrin activating antibody (Fig. 8e,f) . L1CAM knockdown also reduced ILK-dependent F-actin-rich protrusion formation on matrigel (Fig. 8g ). Finally, we tested whether β 1 integrin and ILK are required for L1CAM regulation of YAP. ILK knockdown suppressed YAP nuclear localization (Fig. 8h) . In L1CAM-knockdown cells, expression of the constitutively active β 1 integrin mutant T188I (ref. 47 ) restored PAK phosphorylation on collagen-coated plates and YAP nuclear localization in BSCs (Fig. 8i,j) . β 1 integrin T188I partially rescued brain metastatic colonization in L1CAM-knockdown cells whereas wild-type β 1 integrin did not ( Fig. 8k and Supplementary  Fig. 7f ). These results indicate that L1CAM is epistatic to integrin-ILK signalling in YAP activation during cancer cell spreading for the initiation of metastatic outgrowth.
Discussion
Two significant insights emerge from the present work. First, whereas vascular cooption is conventionally viewed as a means for DCCs to access circulating oxygen and nutrients 12 , our data show that L1CAM-dependent vascular cooption in DCCs is an essential source of mechanotransduction inputs for metastatic outgrowth (Fig. 8l) . Second, whereas previous studies have highlighted the existence of diverse mechanisms for organ-specific colonization 4 , this work provides a common pathway that underlies metastatic colonization by DCCs in multiple organs. Moreover, our evidence suggests that this mechanism is required for the growth of both aggressive metastatic cells immediately after extravasation and of DCCs after exit from latency.
Perivascular localization of tumour cells has long been known 48, 49 , and has been variously termed extravascular migratory metastasis, non-angiogenic growth pattern, vascular cooption or pericytic mimicry, depending on context 12 . Extravascular migratory metastasis, also called pericytic mimicry, refers to melanoma emigration from the primary tumour on the surface of vessels without intravasation into the circulation 50, 51 . Non-angiogenic growth observed in liver and lung tumour specimens involves secondary tumour growth with cancer cells adhering to existing capillaries [52] [53] [54] . Vascular cooption classically refers to tumour cells growing exclusively along the vasculature in brain tumours treated with anti-angiogenic therapy 49 . Glioblastoma cell differentiation into pericytes to support tumour angiogenesis has also been reported 55 . Here we use the term pericyte-like spreading to refer to a phenomenon in which disseminated cancer cells spread on capillaries and compete with pericytes for position by using the molecular machinery that pericytes use for interaction with the endothelial basal lamina.
We show that L1CAM-mediated pericyte-like spreading is a general requirement for the initiation of metastatic colonization in multiple organs by different cancer cell types after initial seeding. The fact that L1CAM is expressed in primary tumours suggests that L1CAM may already play a role in primary tumour growth by engaging vascular or non-vascular extracellular matrix in that context. L1CAM is present at the interface of cancer cells with each other, both in experimental models and clinical samples, suggesting that L1CAM homotypic interactions may also contribute to metastatic growth. The inability of constitutively active β 1 integrin to fully rescue defective metastasis in L1CAM-knockdown cancer cells supports this idea. The role of L1CAM-mediated interactions during primary tumour growth remains to be determined.
In the course of elucidating the molecular mechanism of metastatic cell spreading on blood capillaries, we discovered that pericytes also express and use L1CAM (Fig. 8l) , and this function is particularly crucial during vascular stress and neovascularization. L1cam-knockout mice do not present with vascular defects during development, suggesting that L1CAM is dispensable for vascularization in the absence of stress 16 . This may be due to the abundance of endothelium-derived growth factors that mediate pericyte recruitment and investment during development 56 . Whereas pericytes use L1CAM and ILK for spreading and regulation of vascular function, in metastatic cells L1CAM-ILK signalling results in YAP nuclear translocation and transcriptional activity, which licenses DCCs for growth in the nutrient-rich environment of the perivascular niche. YAP/TAZ and the associated TEAD are well-established promoters of tumour growth and metastasis, and several of the inhibitory components of the Hippo pathway are tumour suppressors 33 . However, aberrant YAP activation by deletion of the inhibitory LATS kinase has been shown to impede tumour growth by increasing immune infiltration in the tumour 57 . These observations suggest that balanced activation of YAP by regulatory inputs including L1CAM-ILK engagement is important for metastasis-initiating cells. By identifying a vital L1CAM-ILK-YAP signalling node for metastatic progression in multiple organs, our work highlights strategic vulnerabilities of metastatic cancer that may be amenable to future therapeutic targeting.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41556-018-0138-8.
Articles

NATuRe CeLL BIOLOgY
Methods
Cell culture. Metastatic derivatives of the MDA-MB-231 human triple-negative breast cancer cell line, including the brain metastatic MDA-MB-231-BrM2a (MDA231-BrM) 20 , the bone metastatic MDA-MB-231-1833 (MDA231-BoM) 58 and the lung metastatic MDA-MB-231-LM2-4175 (MDA231-LM) 21 , HCT116 human colon cancer and metastatic 393N1 Kras/p53-mutant mouse lung adenocarcinoma cell lines were cultured in DMEM with 10% FBS, 2 mM L-glutamine, 100 IU penicillin and 100 μ g ml −1 streptomycin. 393N1 cells were a gift from T. Jacks, Massachusetts Institute of Technology 25 . The BrM3 brain metastatic derivative of the H2030 KRAS-mutant human lung adenocarcinoma cell line 19 (abbreviated as H2030-BrM), a multi-organ metastatic derivative of the 786-O human clear cell renal cell carcinoma cell line (786-M1A) 59 and a latency-competent derivative of the HCC1954 human HER2
+ breast carcinoma cell line (HCC1954-LCC1) 10 were cultured in RPMI 1640 media with 10% FBS, 2 mM L-glutamine, 100 IU penicillin and 100 μ g ml −1 streptomycin. Primary human brain pericytes, astrocytes and brain microvascular endothelial cells were cultured in media supplied by the provider (ScienCell). The MCF10A human mammary breast epithelial cell line and primary normal mammary epithelial cells were cultured in mammary epithelial cell growth medium (MEGM) Bulletkit (Lonza) according to the manufacturer's instructions. Human umbilical vein endothelial cells were cultured according to the supplier's specifications (Angiocrine Bioscience). 293T human embryonic kidney cells were cultured in DMEM with 10% FBS, 2 mM L-glutamine. All cells were free of mycoplasma.
Animal studies. All animal experiments were conducted in accordance with protocols approved by the MSKCC Institutional Animal Care and Use Committee and were in compliance with the relevant ethical regulations regarding animal research. Athymic NCR nu/nu mice (Envigo, 069) and NOD.CB17-Prkdcscid/ NCrHsd mice (Envigo, 170), C57BL/6J (Jackson Labs, 000664) were used between ages 4-7 weeks of age. For mammary fat pad injections and intracardiac injections, 1 × 10 5 cells were delivered in 100 µ l of PBS. For tail vein and intrasplenic injections, 1.5 × 10 5 cells and 50-100,000 cells were delivered in 100 μ l of PBS, respectively 20 . Metastatic colonization was monitored weekly as previously described by BLI using retro-orbital injection of D-luciferin (150 mg kg ) and the IVIS Spectrum Xenogen instrument (Caliper Life Sciences) 13 . Data was analysed using Living Image software v.2.50. For mammary fat pad experiments, BLI readings were normalized to tumour volume by subtracting the background signal from each lung and dividing the remainder by total palpable tumour volume for each mouse. For brain metastasis experiments, at the end point, animals were anesthetized with 100 mg kg −1 ketamine and 10 mg kg −1 xylazine, retro-orbitally injected with D-luciferin. Isolated brains were analysed using IVIS Spectrum Xenogen and Living Image software. 5-10 animals were used per experimental condition. Sample sizes were determined using Mead's resource equation with 8 degrees of freedom and based on prior experience with metastatic animal models effect size. For doxycycline-inducible knockdowns, mice were given doxycycline hyclate in the diet (Envigo) and water (Sigma). Animals were randomly assigned to doxycycline or control groups. For experiments with HCC1954-LCC1 cells, mice were treated with doxycycline in the diet 2 days before NK cell depletion with anti-asialo-GM1 antibody 60 (Wako Chemical, 33 μ g of antibody injected into the peritoneum every 5 days). All animal experiments were statistically analysed using Mann-Whitney rank sum test. No assumptions were made on the normal distribution of the data. For angiogenic plug and Evans blue dye extravasation experiments, Cspg4-CreERT2 mice (Jackson Laboratory, no. 008538) were crossed with L1cam flox/flox mice 39 . 8-10-week-old Cspg4-CreERT2 L1cam flox/y male mice were injected with either 100 μ l of corn oil or 100 μ l of 1 mg ml −1 tamoxifen dissolved in corn oil twice a day for 5 consecutive days and let to recover for 2 days. For angiogenic plug 41 experiments, 500 μ l of growth factor reduced phenol red-free matrigel, containing 200 ng ml −1 recombinant murine vascular endothelial growth factor 165 (PeproTech), 500 ng ml −1 recombinant murine fibroblast growth factorbasic (PeproTech) and 100 μ g ml −1 Heparin (Sigma) was injected subcutaneously on each side of the groin on the ventral side of the mice. 100 μ l of 1 mg ml −1 tamoxifen injected once a day for 5 consecutive days and angiogenic plugs were removed on the 7th day embedded in paraffin and sectioned for H&E staining. Erythrocyte area was measured by staining the paraffin embedded matrigel tissue with TER119 antibody (BD biosciences, 550565, 0.3 μ g ml
−1
). Slides were scanned using a Mirax scanner equipped with a 20× air objective. Area of the matrigel was manually annotated to separate the surrounding fat and skin tissue. The TER119-positive area was measured using Fiji (code available upon request). For Evans blue dye extravasation assay, mice were injected with 2 mg kg −1 lipopolysaccharide to induce systemic blood vessel leakage 37 . 24 h later, 1% (weight/volume) Evans blue dye was injected into the peritoneum. Two hours later, abdominal skin of the mice were collected, weighed and treated with formamide (Sigma-Aldrich) for 48 h at 50 °C. Optical density of Evans blue dye absorbance released from tissue was measured at 600 nM using a spectrophotometer.
Tissue processing and imaging. Isolated mouse brains were fixed in 4% PFA overnight at 4 °C. Mouse lungs were perfused with PBS and 4% PFA and postfixed for at least 4 h at 4 °C. Fixed tissues were washed three times with PBS and incubated with 15% and 30% sucrose for 24 h at 4 °C. Dehydrated tissues were frozen in optimal cutting temperature (O.C.T., Tissue-Tek) solution on a Microm KS34 freezer unit at − 35 °C and cut into 80 μ m sections using Microm HM 450 microtome (Thermo Scientific). Lungs were aliquoted into 5 consecutive sections and brains into 10. Sections were blocked and stained free floating in 10% normal goat serum, 2% BSA and 0.25% Triton-X. All sections were mounted on a glass slide with ProLong Gold Antifade mounting media (Thermo Scientific) and stored in − 20 °C until imaging. Sections were scanned with 3DHISTECH Pannoramic confocal scanner using a 20× air objective. Representative images were acquired using Leica SP5 using a 63× oil objective. Images were analysed using Metamorph, Fiji and CaseViewer softwares. A 3D reconstruction of confocal images was done using Imaris software. Protrusions in the lungs were defined as cell projections that extended more than 2 μ m from the cell body and were manually counted. Cell spreading was measured using Fiji software by drawing an outline around each cell and calculating roundness using the formula: 4 × area× (π × (major axis) 2 ) −1
. YAP localization was quantified using one circular selection with a 0.52 μ m diameter to sample YAP staining intensity within the nucleus and cytoplasm. The ratio of median intensities of each selection area was calculated using Fiji (code available upon request).
In vitro experiments. For integrin activation, 2 × 10 6 cells were plated in a 10 cm tissue culture dish, deprived of serum for 24 h. The next day cells were detached using 5 mM EDTA in PBS and collected with 0.01% (weight/volume) bovine serum albumin. Cells were resuspended in serum free media and counted. 5 × 10 5 cells were allowed to adhere for 1 h on 6-well dishes coated either with on collagen I (5 μ g cm -2 ) (BD Biosciences) or with poly-L-lysine (4 μ g cm -2 ). Cells were then lysed with 60 mM Tris/HCl, 1% SDS, 10% glycerol and 0.2% 2-mercaptoethanol. For antibody-mediated integrin activation, 2.5 × 10 5 cells were plated on 6-well dishes, deprived of serum for 24 h and stimulated with 5 μ g ml -1 β 1 integrin antibody clone TS2/16 (ref. ) in 10% normal goat serum, 2% BSA and 0.25% Triton-X and 0.05% Tween-20. After the staining, 50 fields of view from each well were imaged using a Zeiss Axio Imager M1 equipped with a 40× air objective. Integrated intensity values from each cell were calculated by Fiji (code available upon request). For co-immunoprecipitation experiments, cells were lysed with a lysis buffer containing 0.3% NP40, 150 mM NaCl, 50 mM Tris-Cl (pH 7.4), 2 mM EDTA (pH 8.0) and 10 mM NaF. Antibodies for L1CAM (5G3, Thermo Fisher Scientific, 14-1719-82, 1 μ g ml ) and ankyrin 2 (Santa Cruz Biotechnology, sc-28560, 4 μ g ml ) were incubated with cell lysates overnight followed by a 2 h incubation with A/G Plus Agarose Beads (Thermo Fisher Scientific). Measurement of actin-rich protrusions were done by plating serum-deprived cells on 80 μ l growth factor reduced Matrigel (Corning Biosciences) in 4-well Lab-Tek dishes (Electron Microscopy Sciences) in serum-free media containing 2% matrigel. Cells were fixed 24 h later and stained with Alexa 568 conjugated phalloidin (1:40) (Cell Signaling Technologies). Images were taken using a Zeiss Axio Imager Z1 microscope with 20× air objective and a Zeiss AxioCam HRc camera. Representative cells were imaged using Leica SP5 confocal microscope with Leica Application Suite Lite v2.6 and Leica HyD Camera with 63× oil objective. For endothelial cell co-culture experiments, pericytes, H2030-BrM cells, primary normal mammary epithelial cells, MCF10A cells and 293T cells were labelled with CellTracker Green CMFDA (Thermo Fisher Scientific, C7025) according to the manufacturer's instructions. 4 × 10 3 labelled test cells were plated together with non-labelled 1 × 10 5 endothelial cells in endothelial cell media on 100 µ l of growth factor reduced matrigel to allow for endothelial cell tubule formation 62 in 4-well Lab-Tek dishes. 24 h later cell spreading was imaged using EVOS imaging (Thermo Fisher Scientific) at 20× magnification. All in vitro and ex vivo experiments were statistically analysed using Mann-Whitney rank sum test. No assumptions were made on the normal distribution of the data. Organotypic brain slice culture. Brains were isolated in 1 × HBSS buffer as previously described 63 . Isolated brains were sectioned into 250 μ m slices using Leica VT100S systems. Brain tissue slices were cultured on 0.8 μ m pore size membranes (Millipore) floating on brain slice media. 1 × 10 4 cancer cells were introduced onto the brain slice and incubated for 48 h. Sections were fixed in 4% PFA in PBS overnight at 4 °C and labelled with primary and secondary antibodies in 10% normal goat serum, 2% BSA and 0.25% Triton-X. For timelapse confocal imaging of cancer cell displacement of pericytes, Cspg4-DsRed mice (The Jackson Laboratory, stock no. 008241) were anaesthetized using 100 mg kg -1 ketamine and 10 mg kg −1 xylazine. 0.5 mg ml −1 DiD (DiIC 18 (5)) solid dye in ethanol was further diluted to 0.05 mg ml −1 in 30% sucrose-PBS. 1 ml of this dye was injected into the left ventricle of the anaesthetized mouse to label the endothelial cells. After 1 min of incubation, excess dye was washed with 5 ml of PBS injection to the left ventricle of the mouse. Brain was collected in Articles NATuRe CeLL BIOLOgY 1× HBSS and sectioned as above, in the dark and delivered to culture. 3 × 10 4 CellTracker green labelled H2030-BrM cells added on top of the brain slice. After 24 h of incubation under slice culture conditions, brain slices were placed on hydrophilic Millicell cell culture inserts (Millipore, PICM0RG50) and transferred over to a glass bottom Fluorodish (World Precision of Instruments). Time-lapse images were taken using SP5 or SP8 inverted confocal microscopes (Leica) using a long-distance 20× oil objective every 20 min for 14-20 h. Pericyte displacement was determined by the ability of cancer cell to wedge between a pericyte and DiD-labelled endothelium after a side-by-side encounter of a pericyte and a cancer cell on the same blood vessel. We noticed occasional disappearance of cells from the field of view during the time lapse, which may be due to a shift in the plane of view because of the relaxation of the polytetrafluoroethylene culture insert holding the brain slices. For YAP promoter report assays, RFP expression was driven by YAP responsive promoter in a lentivirus construct. RFP was tagged at the C terminus to a mutant (R12H/N18T/V19A/G67S) Escherichia coli folA dihyrofolate reductase (Addgene no. 29236), which targets the fused protein for proteasomal degradation in the absence of its small-molecule stabilizer trimethoprim (TMP) 31 . H2030-BrM and MDA231-BrM cells were seeded on brain slice cultures for 24 h and were treated with 10 μ M final TMP for another 24 h. Fixed brain slices were immunostained for GFP (Aves Labs, GFP-1010, 10 μ g ml ) and CD31 (BD Biosciences, 550274, 0.0625 μ g ml −1 ). Sections were scanned with 3DHISTECH Pannoramic confocal scanner. GFP-positive cancer cells associated with CD31-positive blood vessels were analysed for RFP expression using Fiji (code available upon request). For translating ribosome affinity purification 3 × 10 4 cancer cells transduced with L10a-EGFP were cultured as above. Lysates for 7 brain slices were combined and processed with TRAP protocol as previously described 64 . Brain slices were lysed with TRAP lysis buffer (20 mM HEPES, pH7.3, 150 mM KCl, 5 mM MgCl2, 1% NP-40, with protease inhibitor cocktail, 0.5 mM DTT and RNasin added fresh before use) and L10a-EGFP was immunoprecipitated with GFP antibodies (clone number 19F7 &19C8, MSKCC Monoclonal Antibody Core Facility) [64] [65] [66] . The quality and quantities of RNA samples purified from anti-EGFP immunoprecipitation products were determined using Agilent BioAnalyzer 2100. RNA-Seq libraries were prepared with TruSeq RNA Sample Prep kit v2 (Illumina) following manufacturer's instructions. RNA-Seq was performed on a HiSeq2000 platform using TruSeq SBS Kit v3 (Illumina). Sequencing reads were mapped to human genome hg19 with STAR 2.3.0. Mapped reads were counted with HTSeq v5.4.0. Raw and normalized counts were analysed in R-studio with DESeq2 package 67 (Bioconductor) and gene set enrichment analysis was performed using previously established signatures [68] [69] [70] .
Clinical samples and immunohistochemistry. Formalin-fixed paraffin embedded tissue sections from 10 cases of L1CAM + invasive breast and lung cancer patients and brain tissue obtained at an autopsy from an ER + breast cancer patient were obtained under an MSKCC Institutional Review Board (IRB) approved biospecimen protocol from the MSK Department of Pathology. Studies described here were all in compliance with the relevant ethical regulations regarding research involving human participants. Samples were selected based on availability of sufficient quantity of formalin-fixed paraffin-embedded metastatic tissue from patients who had given pre-operative consent to tissue utilization for research purposes. Paraffin blocks were serially sectioned and each section was independently immunostained using the Ventana Discovery XT: L1CAM, CD31 (Roche, 760-4378, 0.83 μ g ml
), panKeratin (4.63 μ g ml −1 ) or Leica Bond XT (YAP) by Pathology Core Facility using standard automated techniques. L1CAM + metastatic clusters were scored for YAP nuclear staining in the adjacent section. For mouse tissue, immunohistochemistry was performed as for human samples except that L1CAM staining was performed using a Leica BOND RX platform using a mouse-on-mouse kit (Stat Labs). Antibodies used were L1CAM (CD171 Clone 14.10, Biolegend, SIG-3911, 0.5 μ g ml ), CD31 (Dianova, SZ31, 1 μ g ml ). For image alignment studies, each of the L1CAM IHC image and YAP IHC image obtained from the adjacent sections were segmented independently. Regions encapsulating the nuclei of L1CAM positive cells were dilated to calculate an L1CAM intensity value for each cell. These regions of interest were then assigned a YAP nuclear signal intensity based on nearest neighbour analysis (code available upon request).
Reagents. Phospho-PAK1/2 Ser199/Ser202 (2605, 36 ng ml −1 ), total PAK (2604, 24 ng ml ) antibodies for western blotting were from Cell Signaling Technologies. L1CAM (UJ127.11, sc-53386, 1 μ g ml
), ankyrin 2 (western blot, sc-12718, 1 μ g ml
; IP, sc-28560, 4 μ g ml ) and activating β 1 integrin (TS2/16) (5 μ g ml −1 , sc-53711) antibodies were from Santa Cruz Biotechnology. L1CAM antibody 5G3 for immunoprecipitation was from Thermo Fisher Scientific, 14-1719-82, 1 μ g ml −1
. Antibodies for immunofluorescence used were GFP (Aves Biosciences, GFP1010, 10 μ g ml
), CD31 (BD Biosciences, 550274, 0.0625 μ g ml
), collagen IV (Abcam, ab6586, 4 μ g ml
), YAP1 (Abcam, ab52771, 344 ng ml ) and Alexa 647 conjugated isolectin B4 (4 μ g ml −1 ) (Thermo Fisher Scientific). Anti-NG2 chondroitin sulfate proteoglycan (AB5320, 4 μ g ml
) and anti-O4 antibody, clone 81 (MAB345, 10 μ g ml −1
) were from EMD Millipore, PDGFR-β (14-1402-82, 2 μ g ml −1 ) was from eBioscience and Nkp46 antibody (AF2225, 1 μ g ml −1 ) was from R&D systems. TaqMan probes were all predesigned from Thermo Fisher Scientific. Latrunculin A was from Tocris. pQCXIH-Myc-YAP (Addgene no. 33091), pQCXIH-Myc-YAPS5A (Addgene no. 33093), pQCXIH-Myc-YAP S94A (Addgene no. 33094) were kind gifts from K. Guan (University of California, San Diego). All viruses were infected at MOI of 1-1.6. All constitutive knockdown plasmids were based on pLKO.1 (Dharmacon): L1CAM (TRCN0000063913, TRCN0000063916, TRCN0000063917), L1cam (TRCN0000094553), ANK2 (TRCN0000064911), ILK (TRCN0000000970, TRCN0000000971, V3THS_365604), YAP (TRCN0000107265, TRCN0000107268, V2THS_65509), WWTR1 (TRCN0000019471, TRCN0000019473). Inducible knockdown plasmids were based on mir30 for HCC1954 cells and on mirE 71 for H2030 BrM, MDA231-BoM and MDA231-LM cells with the following target sequences:
1. CTCGAGAAGGTATATTGCTGTTGACAGTGAGCGAAGGGATGGTGTC-CACTTCAAATAGTGAAGCCACAGATGTATTTGAAGTGGACACCATC-CCTCTGCCTACTGCCTCGGACTTCAAGGGGCTAGAATTC 2. CTCGAGAAGGTATATTGCTGTTGACAGTGAGCGCCAGCAAGATCTTGCACATCAATAGTGAAGCCACAGAtGTATTGATGTGCAAGATCTt-GCTGTTGCCTACTGCCTCGGACTTCAAGGGGCTAGAATTC Statistics and reproducibility. Statistical analyses were performed with GraphPad Prism. No assumptions were made about normal distribution of data. MannWhitney tests were used for all the experiments except otherwise stated. All tests performed were two-sided. No data were discarded during the statistical analyses. Blinding of the BLI readings was not possible. Animals were randomly assigned to doxycycline or control groups in Fig. 3 , Fig. 5 and Supplementary Fig. 7 . Animals were randomly assigned to control and tamoxifen treatment groups in Fig. 7 . All statistics were derived from biological replicates with the number of samples quantitated written under each figure legend. All immunoblots were reproduced at least twice with similar results and number of replication is stated in each figure legend. All in vitro and ex vivo experiments where statistics were derived were reproduced at least twice with similar results and with number of replication stated in each figure legend. Time-lapse confocal imaging in Fig. 1 and Supplementary Fig. 1 was done on separate days with independent mouse brain preparations with similar results for each cell line with each biological replicate given. Animal experiments were presented with each biological replicate shown for all experiments.
Code availability. All programming codes are available from the corresponding author on reasonable request.
Data availability. RNA-seq data that support the findings of this study have been deposited in the Gene Expression Omnibus (GEO) under the accession code GSE82281 and also in Supplementary Supplementary Fig. 8 . All other data supporting the findings of this study are available from the corresponding author on reasonable request.
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Data analysis BLI Data was analyzed using Living Image software v.2.50. For mammary fat pad experiments, BLI readings were normalized to tumor volume by subtracting the background signal from each lung and dividing the remainder by total palpable tumor volume for each mouse. Cell spreading was measured using Fiji software by drawing an outline around each cell and calculating roundness using the formula 4 x Area x (π x (Major axis)2)-1. YAP localization was quantified using one circular selection with a 0.52-micron diameter to sample YAP staining intensity within the nucleus and cytoplasm. The ratio of median intensities of each selection area was calculated using Fiji (Code available upon request). GFP positive cancer cells associated with CD31 positive blood vessels were analyzed for RFP expression using Fiji (Code available upon request). For TRAP experiments, sequencing reads were mapped to human genome hg19 with STAR 2.3.0. Mapped reads were counted with HTSeq v5.4.0. Raw and normalized counts were analyzed in R-studio with DESeq2 package66 (Bioconductor) and gene set enrichment analysis was performed using previously established signatures.For image alignment studies, each of the L1CAM IHC image and YAP IHC image obtained from the adjacent sections were segmented independently. Regions encapsulating the nuclei of L1CAM positive cells were dilated to calculate an L1CAM intensity value for each cell. These regions of interest were then assigned a YAP nuclear signal intensity based on nearest neighbor analysis (code available upon request).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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The datasets generated and analysed during the current study are available in GEO datasets under accession number GSE82281: http://www.ncbi.nlm.nih.gov/geo/ query/acc.cgi?token=gjgxkcykbpadzgz&acc=GSE82281.
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Sample size Sample size determination was described under Methods section, subheading: animal studies. Briefly, sample sizes were determined using Mead's resource equation with 8 degrees of freedom and based on prior experience with metastatic animal models effect size Data exclusions No data was excluded from the studies.
Replication
Biological replicates of each experiment is stated under each figure legend and all attempts were successful.
Randomization Animals were randomly assigned to doxycycline or control groups in Figure 3 and Supplementary Figure 7 . Animals were randomly assigned to control and tamoxifen treatment groups in Figure 7 .
Blinding
Blinding of bioluminescent imaging studies were not possible due to tagging of animals but BLI readings were measured by 5 different authors through out the manuscript.
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